China Pharma Holdings (CPHI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 4,529 | 7,011 | 8,104 | 9,642 | 10,867 |
| Cost of Goods | 6,515 | 7,292 | 8,598 | 9,293 | 8,914 |
| Gross Profit | -1,986 | -281 | -494 | 349 | 1,953 |
| Operating Expenses | 3,118 | 2,763 | 3,653 | 3,502 | 5,445 |
| Operating Income | -4,589 | -2,752 | -3,549 | -2,861 | -2,578 |
| Interest Expense | 154 | 334 | 435 | 542 | 294 |
| Other Income | 7 | 7 | 11 | 3 | 6 |
| Pre-tax Income | -4,736 | -3,079 | -3,973 | -3,400 | -2,867 |
| Net Income Continuous | -4,736 | -3,079 | -3,973 | -3,400 | -2,867 |
| Net Income | $-4,736 | $-3,079 | $-3,973 | $-3,400 | $-2,867 |
| EPS Basic Total Ops | -2.70 | -9.10 | -37.80 | -37.00 | -35.00 |
| EPS Basic Continuous Ops | -2.71 | -9.10 | -37.80 | -36.85 | -32.86 |
| EPS Diluted Total Ops | -2.70 | -9.10 | -37.80 | -37.00 | -35.00 |
| EPS Diluted Continuous Ops | -2.71 | -9.10 | -37.80 | -36.85 | -32.86 |
| EPS Diluted Before Non-Recurring Items | N/A | -9.10 | -38.00 | -35.00 | -35.00 |
| EBITDA(a) | $-1,971 | $2 | $-848 | $477 | $101 |